Lupin to focus on new product infusion in FY13 – MoneyControl.com

Antara, the Fenofibrate market as such, degrew by about 18%. Our brand degrew by about 6%. Having said that, the prescriptions of Antara grew by about 3% and to me, that’s a positive mark because while the market is degrowing and there is a …

Posted in Uncategorized